Volibo R 0.2/1 mg

Volibo R 0.2/1mg is an oral antidiabetic agent containing two active ingredients, Voglibose and Repaglinide, which helps your pancreas produce more insulin and lower blood glucose. The combination drug is used to control type 2 diabetes as an add on to diet and exercise. Usually, treatment begins when diet, exercise, and weight reduction alone have not been able to control our blood sugar. Type 2 diabetes is a disease in which your pancreas does not make enough insulin to control the sugar in blood or where your body does not normally respond to the insulin it produces. It is a lifelong disorder that can affect your everyday life. Lowering blood sugar is an essential part of diabetes management. If you achieve control over blood glucose levels, you can likely reduce the risk of getting serious complications of diabetes such as eye damage, nerve problems, kidney impairment/damage, and loss of limbs. Repaglinide reduces blood glucose by stimulating the release of insulin from the pancreas. At the same time, Voglibose inhibits the intestinal enzymes that cause the breakdown of complex sugars into simple sugars such as glucose. Together, they prevent blood glucose from rising very high just after meals.